CD34 and myelodysplastic syndrome: A direct involvement of the T cell subsets in relation to CD34+ blasts and their role in the biology of MDS/sAML is further supported by the finding that these cells were detected with the highest frequency in sAML patients with a blast count of >30%, a threshold known to describe a more accelerated subset of sAML.